Helicobacter Pylori Infection in Patients with End-Stage Renal Disease

Recurrence of peptic ulcer in uraemic and non‐uraemic patients after Helicobacter pylori eradication: a 2‐year study

“…Therefore, H. pylori infection may not be an important cause of peptic ulcer in patients with ESRD. Moreover, although some authors have observed the effect of H. pylori on gastrin and pepsinogen in these patients, the effect of eradication of H. pylori on the recurrence of peptic ulcer in these patients remains unclear 27–29 . Therefore, it is interesting to observe the outcomes after eradication therapy in these patients.…”

“…observed that mortality because of UGI pathology is high in the first 2 years of hemodialysis 37 . In addition, the incidence of peptic ulcer declines as the duration of haemodialysis increases 29 . These observations can be explained by the report that long‐term dialysis might reduce gastric acid secretion 9 .…”

The Effects of Continuous Ambulatory Peritoneal Dialysis and Hemodialysis on Serum Pepsinogen Concentrations in Patients with Chronic Renal Failure

“…We investigated the prevalence of H. pylori and found no differences between the groups. In the majority of the studies investigating H. pylori prevalence in patients with CRF, no significant difference in the H. pylori frequency was detected between the patients with and without CRF (Fabrizi and Martin 2000). The prevalence of H. pylori is approximately 70% in Turkish population (Us and Hascelik 1998).…”

Emergency Gastrointestinal Bleeding in DialysisPatients:Five Years' Experience in a Single Dialysis Center

“…Interestingly, the literature suggests that the detection rate of H. pylori may vary according to the detection method used and the reporter. 6 For instance, Nakajima et al 7 Compared differences in the detection of H. pylori using an antibody or biopsy method in HD or renal failure patients, and a control group of aged-matched, healthy people. Patient groups testing positive were in descending order as follows: the control group, patients with renal failure, and dialysis patients.…”